Roque A Cecília A, Taipa M Angela, Lowe Christopher R
Centro de Engenharia Biológica e Química, Instituto Superior Técnico, Lisboa, Portugal.
J Mol Recognit. 2005 May-Jun;18(3):213-24. doi: 10.1002/jmr.733.
Rational design and combinatorial chemistry were utilized to search for lead protein L (PpL) mimetics for application as affinity ligands for the purification of antibodies and small fragments, such as Fab and scFv, and as potential diagnostic or therapeutic agents. Inspection of the key structural features of the complex between PpL and human Fab prompted the de novo design and combinatorial synthesis of a 169-membered solid-phase ligand library, which was assessed for binding to human IgG and subsequent selectivity for the Fab fragment. Eight ligands were selected, chemically characterized and compared with a commercial PpL-adsorbent for binding pure immunoglobulin fractions. The most promising lead, ligand 8/7, when immobilized on an agarose support, behaved in a similar fashion to PpL in isolating Fab fragments from papain digests of human IgG to a final purity of 97%.
利用合理设计和组合化学来寻找铅蛋白L(PpL)模拟物,用作亲和配体,用于纯化抗体和小片段,如Fab和scFv,以及作为潜在的诊断或治疗剂。对PpL与人Fab复合物的关键结构特征进行检查后,进行了169元固相配体文库的从头设计和组合合成,并评估了其与人IgG的结合以及对Fab片段的后续选择性。选择了8种配体,进行化学表征,并与商业PpL吸附剂比较,用于结合纯免疫球蛋白组分。最有前景的先导物配体8/7固定在琼脂糖载体上时,在从人IgG的木瓜蛋白酶消化物中分离Fab片段方面,表现与PpL类似,最终纯度达到97%。